Rezvilutamide
Rezvilutamide (SHR3680) is an orally bioavailable, brain-penetrant androgen receptor antagonist. It demonstrates antitumor efficacy in preclinical models of prostate cancer, including studies involving castration-resistant and metastatic disease, supporting its research use in this field.
Product Specifications
CAS Number
1572045-62-5
Product Name Alternative
AndrogenReceptor, Androgen Receptor, Rezvilutamide, SHR 3680, SHR3680, SHR-3680
Field of Research
Metabolism Research
Purity
99.96% (May vary between batches)
Solubility
DMSO:80 mg/mL (166.85 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.88 mM)
Smiles
CC1 (C) N (C (=S) N (C1=O) c1ccc (C#N) c (c1) C (F) (F) F) c1ccc (OC[C@@H] (O) CO) cc1
Molecular Formula
C22H20F3N3O4S
Molecular Weight
479.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15091706 1 Vial
Lentiviral human C9orf47 shRNA (UAS) - Lentiviral human C9orf47 shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details 
REPCB1009 1 mL
PCB 1x Element Congener PCB-22 100ug/mL in Isooctane - 1ML
Sign In for Pricing
View Details RPU61306-02 100 µg
Mouse Pulmonary Surfactant Associated Protein A1
Sign In for Pricing
View Details MBS1006319-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O127:H6 Ribulokinase (araB)
Sign In for Pricing
View Details